The panel discussed the movement of biomedical innovations from research labs to real world while emphasizing on the fact that successful technology transfer depends on a multitude of factors such as scalability, market readiness, procurement options, and clear healthcare need. The discussion focused on addressing funding and structural challenges, focusing on market problems, and building scalable solutions to ensure biomedical innovations translate into meaningful healthcare outcomes.